IMGT Corp. Ltd. develops innovative tumor treatment via image guided therapy. It specializes in ultrasound mediated drug (or) gene delivery method. The company was founded on April 5, 2010 and is headquartered in Seongnam, South Korea.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company